<DOC>
	<DOCNO>NCT00369863</DOCNO>
	<brief_summary>To determine efficacy safety intravitreal triamcinolone acetonide refractory diabetic macular edema .</brief_summary>
	<brief_title>A Randomized , Placebo-Controlled Clinical Trial Intravitreal Triamcinolone Refractory Diabetic Macular Edema</brief_title>
	<detailed_description>Overall 80 % diabetic patient low vision nonproliferative stage main cause decrease visual acuity macular edema . According early treatment diabetic retinopathy study ( ETDRS ) , treatment choice diabetic macular edema ( DME ) laser therapy , may neither effective curative patients.There many case refractory laser treatment suitable candidate . Corticosteroids might beneficial effect DME . They use different dos route ( periocular , intravitreal , slow release implant ) variety retinal disease . Recently , prospective randomize study , concern effect intravitreal triamcinolone acetonide ( IVT ) DME publish . In two-year result , Gillies et al . conclude IVT improved vision reduce macular thickness eye refractory diabetic macular edema . They show beneficial effect persist 2 year repeat treatment . We also conduct randomized placebo-controlled clinical trial determine safety efficacy IVT intractable DME . Besides , tried evaluate effect intervention angiographic finding patient .</detailed_description>
	<mesh_term>Macular Edema</mesh_term>
	<mesh_term>Edema</mesh_term>
	<mesh_term>Triamcinolone hexacetonide</mesh_term>
	<mesh_term>Triamcinolone Acetonide</mesh_term>
	<mesh_term>Triamcinolone</mesh_term>
	<mesh_term>Triamcinolone diacetate</mesh_term>
	<criteria>Clinically significant macular edema ( CSME ) Clinically significant macular edema ( CSME ) refractory initial supplemental macular photocoagulation Monoocular patient History vitrectomy Glaucoma ocular hypertension Significant medium opacity Traction macula</criteria>
	<gender>All</gender>
	<minimum_age>44 Years</minimum_age>
	<maximum_age>79 Years</maximum_age>
	<verification_date>February 2007</verification_date>
	<keyword>Cystoid macular edema</keyword>
	<keyword>Diabetic macular edema</keyword>
	<keyword>Hard exudate</keyword>
	<keyword>Intravitreal triamcinolone</keyword>
	<keyword>Macular thickness</keyword>
</DOC>